Department of Health and Vanderbilt University Chronic Pain Guidelines Symposium Elizabeth Lund, Executive Director, Board of Nursing Linda Johnson, APN.

Slides:



Advertisements
Similar presentations
Aug 7 09 Co-Occurring Service Array Psychiatric Evaluation Comprehensive Evaluation Medication Monitoring Medications Clinical Consultation Family Therapy.
Advertisements

The Physician-PA Team Improving Access to Patient Care.
Changes in APRN Prescriptive Authority SB 406 Kathy Hutto Governmental Affairs Consultant Jackson Walker L.L.P. 1.
DMAS Office of Behavioral Health
Confidential 1 Electronic Prescribing of Controlled Substances: Prescriber and Agent Workflow Part 3 of a 3 Part Series Chuck Klein, Ph.D. GM/Director,
Pharmacology Information, Rules, and Laws For Medications
COA/CTP Application Process Christine Armstrong, MSN, CNP.
VIRGINIA PRESCRIPTION MONITORING PROGRAM C.A.R.E Presentation February 27, 2015 Ralph Orr Director, Virginia Prescription Monitoring Program.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
School Nurse Practice and Delegation, Coordination and Oversight Presenters: Virginia deLorimier, RN Maine Board of Nursing Nancy Dube, RN Maine Department.
Medication History: Keeping our patients safe. How do we get all of the correct details?
Chapter 3 The Nursing Assistant
H Department of Medical Assistance Services Substance Abuse Intensive Outpatient – SA IOP 2013.
Coordinator University Clinical Research Pharmacy Investigational Drug Service (IDS) Marjorie Shaw Phillips, MS, RPh, FASHP Clinical Research Pharmacist.
The Role of Case Management-Beginning to End Linda Hanf, RN, BSN, CCM, CRRN The Directions Group, Inc.
Area 15 Ryan White Program
Presentation on Chiropractic Assistants
Issues Related to Medication in the Schools Module 3.
Richard Z Aramini, PharmD PGY-1 Pharmacy Practice Resident Bay Pines VA Healthcare Center.
Study visit to LA on Youth Mental Health Programmes Professional Roles & Development for Mental Health Practitioners By Yvonne Chak Hong Kong Christian.
Ethics and Regulatory Approvals Alison Robertson CMDHB Research Officer.
1. 2 Melinda Campopiano, MD Medical Officer Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration U.S. Department.
The Medicare Hospice Benefit and Medicare Part D April 18, 2014 Janis Bivins, RN Marilyn Tatro, RN John Gochnour, Esq.
Module V: Coordinated Care BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
April 15 th is not just the deadline for your taxes!!! Is your documentation complete for Pharmacist to Registered Technician Ratios? Policies.
SCOPE OF PRACTICE: NURSING IN OHIO Pamela S. Dickerson, PhD, RN-BC, FAAN
For Pain or Not for Pain: Methadone Madness
Module V – Coordinated Care BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
2015 Tennessee Controlled Substances Monitoring Database Program D. Todd Bess, Pharm.D. Director Tennessee Controlled Substance Monitoring Database.
FAHA ANNUAL LEGISLATIVE WORKSHOP HANDOUT Assisted Living Facility Changes in Rules and Surveyor Guidelines MARCH 22, 2006.
Retention of Medical Records Law April 2002 Source: records-retention0402.shtml
Texas State Board of Medical Examiners Bruce A. Levy, M.D., J.D.
Nursing Issues Panel Debbie Vierra, RN Delaware Valley Job Corps Center Region 1 Health and Wellness Conference May 14, 2004.
H Department of Medical Assistance Services Substance Abuse Day Treatment 2013.
TNSAM Addiction Medicine. Data source: Tennessee Department of Health, Office of Health Statistics, Death Statistical System. Overdose deaths were defined.
Intro to OBRA and the Nursing Assistant. INTRODUCTION  You need to know:  What you can and cannot do  What conduct is right & wrong  Your legal limits.
V April 2016 Training Guide 1 NOTE: All screen shots from Communicare indicate PCEHR. Any reference to the PCEHR or the My Health Record within this.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
ABC-MAP Act 191 of 2014 September 16, 2016 Pennsylvania’s Prescription Drug Monitoring Program (PA PDMP)
Incidental Medical Services (IMS) Department of
Physician assistants and Advanced practice Nurses who are they?
Medication Assisted Treatment
April 15th is not just the deadline for your taxes
Georgia Nurse Protocol Agreement
Presented by Darra Coleman, Chief Advice Counsel,
Drugs and Prescription Records
Drugs and Prescription Records
Updates Regarding New Physician Assistant Rules
Opioids – A Pharmaceutical Perspective on Prescription Drugs
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Susan y swart Ed.D, rn, cae Executive director Ana-Illinois
April 12, 2017 Guy Reese, Program Integrity Manager
What is the Family and Medical Leave Act?
Health Home Program Services
Laws and Regulations Specific to Hospice
Barbara Allison-Bryan, MD
MEDICAL BOARD OF CALIFORNIA
DATE : 19 June 2018 BY : Palesa Santho
DATA 2000 Waivers The Drug Addiction Treatment Act of 2000 (DATA 2000) permits physicians who meet certain qualifications to treat opioid dependency with.
Prescription Drug Monitoring Program
Update on APRN Telepractice: The Regulatory Perspective
Evergreen Valley College NCLEX Application Review
Prescription Drug Monitoring Program
National Credentialing Forum 2019 San Diego, CA February
Illinois Prescription Monitoring Program
Law, Regulation and Ethics: Do’s and Don’ts of Clinical Rotations
Prescriptive Authority for Nurse-Midwives in Georgia
A Training For Multidisciplinary Addiction Professionals
OSU Controlled Substances Training Module for Researchers
Presentation transcript:

Department of Health and Vanderbilt University Chronic Pain Guidelines Symposium Elizabeth Lund, Executive Director, Board of Nursing Linda Johnson, APN Consultant/Over Prescribing Team

Objectives  Compare the prescribing requirements for APNs and PAs  Understand CSMD registration  List five prescribing guidelines for the treatment of chronic pain  Explain the consequences of overprescribing

Board Requirements APNs with a Certificate of Fitness Physician Assistants  Protocols regarding prescribing required between APN and supervising physician on file at practice site  Protocols to provide selected medical/surgical services between PA and designated primary supervisor on file at practice site  Notice and Formulary filed with BON  PA Supervising Physician Form (attachments 4 & 5) filed with COPA  Change in supervisor or formulary must be within 30 days  Change in designated primary supervisor within 15 calendar days; other changes within 30 application 80.htm

Supervision Requirements  Protocols on site  Chart Review  100% for controlled drugs  20% of all charts  Ensure chart review done  If review not done, consider another supervisor

Number of APNs & PAs with authority to prescribe Only APNs with a Certificate of Fitness to prescribe are eligible to be issued a DEA number APN = 9842 PA = 1769

APN Prescribing Authority by Role NPCRNACNSNMTOTAL Authority to Prescribe 8,4191, ,842 No Authority to Prescribe 521, ,447 Total8,4712, ,289

New to prescribing controlled substances? Remember 30 You MUST register in CSMD within 30 days of obtaining a DEA

But I only prescribe controls a few times a year… “If you provide direct care and prescribe controlled substances to patients in Tennessee for more than 15 days per year or you are a dispenser in practice providing direct care to patients in Tennessee for more than 15 days per year, you are required to register with the CSMD.”

Public Chapter 898 Requires PAs & APNs with a certificate of fitness and their extenders to identify the supervising provider in the CSMD by entering the provider’s driver's license number

CSMD Registration Registration cannot be completed until a supervisory relationship is entered

For each work location, enter “Supervisor’s Driver License Number” and click “Add”

Check appropriate Work Location Click Add Selected Supervisor

Save

Entered but not confirmed

Supervisor Review Pending

Supervisory Relationship Pending Contact your supervising physician to inform that additional action in the CSMD is needed

For Those Registered In CSMD Patient records cannot be accessed until a supervisory relationship is entered and confirmed for each practice location

CSMD Requires Report change in supervising physician within 30 days

Tell Your Board Too!  Updating CSMD does not relieve your responsibility to notify the licensing board of change(s) in supervising physician  APN  30 days  PA  15 days primary supervisor  30 days for all other reportable changes

Public Chapter 396  Requires CSMD to identify the top fifty (50) prescribers of controlled substances and  Send a letter through registered mail to the prescriber and to the physician supervisor

Comparison of Top 50 to Prescribers with DEA Based on DEA data as of 7/31/2015 Based on CSMD for calendar year 2014

APN Prescriber with Two Supervisors  APN Smith supervised by Dr. Doe at Retail Clinic (no controlled substances prescribed) and  Dr. Deer at Pain Clinic (controlled substances prescribed)  File Notice and Formulary with BON, include both Drs. Doe & Deer  Enter Dr. Deer as supervisor in CSMD  Enter Dr. Deer’s d.l. #  Supervisory relationship in CSMD approved by Dr. Deer

PA Changes Supervisor  PA Paddington’s primary supervising physician Dr. Bird retires and is replaced by Dr. Bear  Paddington prescribes controlled substances at the Bear Orthopedic Clinic  PA Paddington notifies the PA Committee by letter of the change in primary supervisory physician (15 days)  PA Paddington deletes retired Dr. Bird on CSMD, enters Dr. Bear and Bear’s d.l. #.  Dr. Bear approves PA Paddington

Who’s responsible for the PA Supervisory Physician Form? By law: YOU ARE! A physician assistant to whom the authority to prescribe legend drugs and controlled substances has been delegated by the supervising physician shall file a notice with the committee containing the name of the physician assistant, the name of the licensed physician having supervision, control and responsibility for prescriptive services rendered by the physician assistant and a copy of the formulary describing the categories of legend drugs and controlled substances to be prescribed and/or issued, by the physician assistant. The physician assistant shall be responsible for updating this information;  T.C.A. § (2)(B)

PA/APN Your Formulary MATTERS THOU SHALL NOT prescribe Schedules II, Ill and IV controlled substances unless such prescription is specifically authorized by the formulary or expressly approved after consultation with the supervising physician before the initial issuance of the prescription or dispensing of the medication;

Schedule II and III Opioids 1supply Schedule II or III opioids listed on the formulary shall only be prescribed for a maximum of a non-refillable, thirty-day course of treatment, unless specifically approved after consultation with the supervising physician before the initial issuance of the prescription or dispensing of the medication.

EVERY Renewal Minimum 2 continuing education hours on controlled substances prescribing including Tennessee Chronic Pain Guidelines every biennial period.

Prior to Initiating Opioid Therapy Think about… Tennessee Chronic Pain Guidelines

Just Because Someone Else Decided To Prescribe Opioids, Does Not Mean You Should A patient having been prescribed opioids by a previous provider is not, in and of itself, a reason to continue opioids.

Pregnancy Is Special All newly pregnant women should have a urine drug test administered by the appropriate women’s health provider.

Are Opioids really necessary? If yes, DOCUMENT!  The patient's medical history  Physical examination  Laboratory tests  Imaging results  Electro-physiologic testing  Other elements supporting the plan of care should be documented in the medical record prior to initiating opioid therapy

Not for Chronic Pain Wrong Reason Methadone/ Buprenorphine

Benzos and Opioids don’t mix Benzodiazepines should be generally avoided in combination with chronic opioid therapy. When the opioid dose reaches 120mg MEDD and the benzodiazepines are being used for mental health purposes, the provider shall REFER to a mental health professional to assess necessity of benzodiazepine medication.

If An Opioid Is Prescribed: Go with lowest dose

When to refer a patient to a Pain Management Specialist? Refer If you are not practicing as a pain specialist refer above 120 MEDD equals

Disciplined License Scenario  Practiced in pain clinic 2 years. “Trained” by the medical director regarding treatment of chronic pain.  Questioned the dosage of prescriptions for certain patients but continued to prescribe.  Not allowed to renew RN license or APN certificate, assessed costs of case

Board Actions Overprescribing Cases n= 98

BME Action Overprescribing BME

BON Action (APN) Overprescribing

Months licensed prior to violation n=24 April 2013 thru June 2015

Behind the Statistics: Louie Miceli player_embedded